Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2022-09-28

FDA Approved: ARTHRITIS PAIN RELIEVER — Supplemental Application (Publix Super Markets Inc)

View source ↗

Summary

FDA approved a supplemental application for ARTHRITIS PAIN RELIEVER (diclofenac sodium) by Publix Super Markets Inc. This action approves changes to the product…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Arthritis Pain Reliever (Diclofenac sodium)

Snippet

SUPPL AP for ARTHRITIS PAIN RELIEVER (DICLOFENAC SODIUM)